New drugs and medical devices are tested for safety and effectiveness in several phases of clinical trials. But how exactly does a clinical trial work? And what is the difference between Phase I and...
Thank you for your continued support of our mission to end Alzheimer’s disease before losing another generation. As 2021 comes to a close, we are excited about the many new opportunities we foresee...
Alzheimer’s disease makes up 60 to 80 percent of all dementias. But what else can cause memory and thinking problems? Learn more about other causes of dementia along with their varied symptoms.
Smartphones and smartwatches already measure our heart rate, sleep patterns and oxygen levels. These and other so-called digital biomarkers coupled with artificial intelligence could one day soon...
A new, NIH-funded, multi-site study is exploring whether computerized brain training can prevent dementia. Preventing Alzheimer’s with Cognitive Training (PACT) will examine whether a specific type...
A new Alzheimer’s clinical trial is recruiting people as young as 55 to participate in a study of an anti-amyloid investigational therapy. The study is groundbreaking because the study medication...
Sleep is your body’s way of restoring vital organs including the brain. When sleep is elusive over long periods of time, research shows it can increase the risk of dementia and cognitive decline. You...
The Alzheimer’s Association surveyed Black, Hispanic, Asian and Native Americans about their access to Alzheimer’s and dementia care. The results, which are reported in the 2021 Facts and Figures...
Researchers are finding COVID-19 can significantly impact the brain. From neurological symptoms to mental well-being, the virus is taking a toll on the brain. In a new report the Global Council on...
Alzheimer’s researchers are seeking new ways to prevent and treat Alzheimer’s disease. Could novel treatments such as vaccines and gene therapy hold the key to a new type of treatment? Researchers...
